Mankind Pharma Ltd
NSE: MANKIND BSE: 543904
₹2240.10
(0.11%)
Wed, 18 Mar 2026, 08:18 pm
Market Cap923.78B
PE Ratio52.03
Dividend0.04
Health Technology
Pharmaceuticals: Major
24.5KMankind Pharma Financials
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total revenue | 58.70B | 62.18B | 77.82B | 87.43B | 102.59B | 122.07B |
| Gross profit | 24.07B | 27.49B | 33.85B | 33.88B | 41.24B | 50.43B |
| Operating expenses (excl. COGS) | -9.52B | -11.65B | -15.23B | -17.70B | -19.42B | -25.63B |
| Selling/general/admin expenses, total | -9.03B | -11.19B | -14.58B | -16.57B | -18.70B | -24.54B |
| Research & development | 0 | -123.71M | -2.13B | -1.88B | -2.23B | -2.32B |
| Selling/general/admin expenses, other | -9.03B | -11.07B | -12.44B | -14.69B | -18.70B | -22.22B |
| Other operating expenses, total | -487.48M | -460.18M | -657.06M | -1.13B | -715.40M | -1.08B |
| Operating income | 14.55B | 15.84B | 18.61B | 16.18B | 21.82B | 24.80B |
| Non-operating income, total | -286.65M | 956.32M | 988.52M | 408.39M | 2.01B | 239.50M |
| Interest expense, net of interest capitalized | -156.42M | -177.83M | -202.31M | -419.88M | -263.10M | -4.08B |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 768.90M | 1.22B | 497.90M | 521.18M | 1.05B | 4.13B |
| Non-operating interest income | 128.03M | 381.86M | 129.17M | 123.92M | 368.30M | 674.90M |
| Miscellaneous non-operating expense | 295.23M | 395.22M | -15.56M | 29.05M | -52.80M | 2.57B |
| Unusual income/expense | -899.14M | -90.61M | 692.93M | 307.09M | 1.22B | 192.10M |
| Pretax income | 14.26B | 16.80B | 19.60B | 16.59B | 23.83B | 25.04B |
| Taxes | -3.82B | -3.99B | -5.22B | -3.62B | -4.57B | -5.10B |
| Non-controlling/minority interest | -257.23M | -276.07M | -194.81M | -278.17M | -288.70M | -201.60M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 10.30B | 12.65B | 14.33B | 12.82B | 19.12B | 19.86B |
| Net income | 10.30B | 12.65B | 14.33B | 12.82B | 19.13B | 19.91B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 10.30B | 12.65B | 14.33B | 12.82B | 19.13B | 19.91B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - |
| EBITDA | 15.54B | 17.03B | 20.28B | 19.44B | 25.60B | 31.01B |
| EBIT | 14.55B | 15.84B | 18.61B | 16.18B | 21.82B | 24.80B |
| Total operating expenses | -44.15B | -46.34B | -59.20B | -71.25B | -80.77B | -97.27B |
| Prepaid expenses | 94.98M | 369.43M | 1.36B | 331.60M | 603.90M | 611.20M |
| Deferred income, current | 40.89M | 124.93M | 165.44M | 263.69M | 497.40M | 329.40M |
| Capital and operating lease obligations | 45.10M | 45.10M | 29.90M | 51.78M | 141.30M | 141.30M |
| Operating lease liabilities | — | — | — | — | — | 140.30M |
| Deferred tax liabilities | 81.67M | 130.32M | 556.21M | 773.12M | 890.70M | 18.13B |
| Deferred income, non-current | — | — | — | — | — | — |
| Minority interest | 1.86B | 1.41B | 1.61B | 1.88B | 2.13B | 2.36B |
| Change in accrued expenses | — | — | — | — | — | — |
| Common dividends paid | -3.64B | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800